R
Rami Musharrafieh
Researcher at University of Arizona
Publications - 29
Citations - 884
Rami Musharrafieh is an academic researcher from University of Arizona. The author has contributed to research in topics: Virus & Antibody. The author has an hindex of 14, co-authored 23 publications receiving 541 citations. Previous affiliations of Rami Musharrafieh include University of New Mexico & Scripps Research Institute.
Papers
More filters
Journal ArticleDOI
Nasal immunity is an ancient arm of the mucosal immune system of vertebrates
Luca Tacchi,Rami Musharrafieh,Erin T. Larragoite,Kyle Crossey,Erik B. Erhardt,Samuel A.M. Martin,Scott E. LaPatra,Irene Salinas +7 more
TL;DR: It is found that NALT is present in rainbow trout and that it resembles other teleost mucosa-associated lymphoid tissues, and is capable of mounting strong anti-viral immune responses following nasal delivery of a live attenuated viral vaccine.
Journal ArticleDOI
Effects of transportation stress and addition of salt to transport water on the skin mucosal homeostasis of rainbow trout (Oncorhynchus mykiss)
TL;DR: The data clearly indicate the skin and skin microbiota of rainbow trout undergo important physiological responses during stress, and a new mechanism by which salt is an effective stress mitigator in some fish species.
Journal ArticleDOI
Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance.
TL;DR: It is discovered that CsA and its analogs have broad-spectrum antiviral activity against multiple influenza A and B strains, including strains that are resistant to either NA or M2 inhibitors or both.
Journal ArticleDOI
An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses
Yanmei Hu,Rami Musharrafieh,Chunlong Ma,Jiantao Zhang,Donald F. Smee,William F. DeGrado,Jun Wang +6 more
TL;DR: This study represents the first report demonstrating the in vivo antiviral efficacy of inhibitors targeting M2 mutants, and suggests that inhibitors targeting drug‐resistant M 2 mutants are promising antiviral drug candidates worthy of further development.
Journal ArticleDOI
Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68)
Rami Musharrafieh,Jiantao Zhang,Peter Tuohy,Naoya Kitamura,Shreya S. Bellampalli,Yanmei Hu,Rajesh Khanna,Jun Wang +7 more
TL;DR: Three compounds 10a, 12a, and 12c were identified to have significantly improved potency and a high selectivity index compared with dibucaine against five different strains of EV-D68 viruses, suggesting they might be further developed for the treatment of both respiratory infection as well as neuronal infection.